Literature DB >> 29714117

Predictive value of big endothelin-1 on outcomes in patients with myocardial infarction younger than 35 years old.

Bing-Yang Zhou1, Xiong-Yi Gao1,2, Xi Zhao1, Ping Qing1, Cheng-Gang Zhu1, Na-Qiong Wu1, Yuan-Lin Guo1, Ying Gao1, Geng Liu1, Qian Dong1, Jian-Jun Li1.   

Abstract

AIM: The predictive value of big endothelin-1 (ET-1) for cardiovascular outcomes in myocardial infarction (MI) patients younger than 35 years old has not been characterized.
METHODS: A total of 565 consecutive MI patients younger than 35 years old were studied and followed up for 37.78 ± 24.9 months.
RESULTS: Multivariable Cox regression analysis showed that big ET-1 was positively correlated with major adverse cardiovascular events [MACEs] (odds ratio: 3; 95% CI: 1.92-4.68; p < 0.001). The area under receiver operating characteristics curve showing the predictive value of big ET-1 on MACEs was 0.67.
CONCLUSION: The study first demonstrated that big ET-1 was an independent predictor for MACEs in MI patients younger than 35 years old.

Entities:  

Keywords:  coronary artery disease; endothelin-1; myocardial infarction; outcome; young

Mesh:

Substances:

Year:  2018        PMID: 29714117     DOI: 10.2217/pme-2017-0044

Source DB:  PubMed          Journal:  Per Med        ISSN: 1741-0541            Impact factor:   2.512


  2 in total

1.  Predictive Value of Plasma Big Endothelin-1 in Adverse Events of Patients With Coronary Artery Restenosis and Diabetes Mellitus: Beyond Traditional and Angiographic Risk Factors.

Authors:  Yue Ma; Tao Tian; Tianjie Wang; Juan Wang; Hao Guan; Jiansong Yuan; Lei Song; Weixian Yang; Shubin Qiao
Journal:  Front Cardiovasc Med       Date:  2022-05-26

2.  Plasma Big Endothelin-1 Levels and Long-Term Outcomes in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Undergoing Percutaneous Coronary Intervention.

Authors:  Si-Qi Lyu; Jun Zhu; Juan Wang; Shuang Wu; Han Zhang; Xing-Hui Shao; Yan-Min Yang
Journal:  Front Cardiovasc Med       Date:  2022-03-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.